FDA — authorised 28 February 1997
- Marketing authorisation holder: FOUGERA PHARMS
- Status: approved
🇺🇸 Pandel in United States
FDA authorised Pandel on 28 February 1997
Marketing authorisations
FDA — authorised 28 February 1997
- Application: NDA020453
- Marketing authorisation holder: ANI PHARMS
- Local brand name: PANDEL
- Indication: CREAM — TOPICAL
- Status: approved
Pandel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Pandel approved in United States?
Yes. FDA authorised it on 28 February 1997; FDA authorised it on 28 February 1997.
Who is the marketing authorisation holder for Pandel in United States?
FOUGERA PHARMS holds the US marketing authorisation.